Related Experiment Video

Updated: May 8, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

[Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous

Yi-ting He1, Ning Tan, Yuan-hui Liu

  • 1Department of Cardiology, Guangdong Academy of Medical Sciences, Guangzhou, China.

Zhonghua Xin Xue Guan Bing Za Zhi
|September 12, 2013
PubMed

Insights

High-sensitivity C-reactive protein (hs-CRP) is linked to contrast-induced nephropathy (CIN) in ST-segment elevated myocardial infarction (STEMI) patients. Higher hs-CRP levels post-percutaneous coronary intervention (PCI) increase the risk of developing CIN.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Context:

  • ST-segment elevated myocardial infarction (STEMI) is a critical cardiovascular condition.
  • Percutaneous coronary intervention (PCI) is a common treatment for STEMI.
  • Contrast-induced nephropathy (CIN) is a significant complication following PCI, particularly in patients with STEMI.

Purpose:

  • To investigate the association between high-sensitivity C-reactive protein (hs-CRP) levels and the incidence of CIN.
  • To determine if hs-CRP can serve as a predictor for CIN in STEMI patients undergoing PCI.

Summary:

  • A study of 220 STEMI patients undergoing primary PCI found a significant positive correlation between hs-CRP levels and CIN incidence.
  • Patients in higher hs-CRP quartiles exhibited a markedly increased risk of developing CIN.
  • Multivariate analysis confirmed hs-CRP as an independent predictor of CIN, even after adjusting for traditional risk factors.

Impact:

  • Identifies hs-CRP as a valuable biomarker for stratifying CIN risk in STEMI patients post-PCI.
  • May guide clinical decision-making and preventive strategies to mitigate CIN development.
  • Contributes to a better understanding of the inflammatory pathways involved in CIN pathogenesis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...